Position in MDXG
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,262,413
+$5,579,448 QoQ
Shares Held
2,665,562
+124.8% QoQ
Ownership
1.83%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 226 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. MDXG ranks #149 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in MDXG
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,262,413 | 2,665,562 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,682,965 | 1,185,561 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,381,906 | 1,090,385 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $8,704,304 | 1,247,035 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,683,675 | 766,559 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $8,796,691 | 914,417 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,883,513 | 657,109 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,847,604 | 699,510 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,811,629 | 624,887 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,255,527 | 485,237 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,008,881 | 412,741 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $3,129,708 | 473,481 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $1,111,427 | 325,932 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $900,917 | 324,071 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $833,094 | 290,277 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $825,852 | 237,998 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $996,070 | 211,480 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $907,973 | 150,327 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $456,286 | 75,295 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $487,251 | 38,949 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,910,007 | 282,525 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $185,767 | 20,459 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||